Bommakanti N (2026). [PMID: 40855963](https://pubmed.ncbi.nlm.nih.gov/40855963/). *Curr Eye Res*. [Clinical Trial Publication]
Ehlers JP (2026). [PMID: 41609778](https://pubmed.ncbi.nlm.nih.gov/41609778/). *JAMA Ophthalmol*. [Clinical Trial Publication]
Ayachit A (2026). [PMID: 42054085](https://pubmed.ncbi.nlm.nih.gov/42054085/). *Indian J Ophthalmol*. [Review / Meta-Analysis]
Wei Y (2026). [PMID: 41237838](https://pubmed.ncbi.nlm.nih.gov/41237838/). *Cellular signalling*. [Basic Science / Preclinical]
Cui M (2026). [PMID: 41618563](https://pubmed.ncbi.nlm.nih.gov/41618563/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Piroozmand S (2026). [PMID: 42080790](https://pubmed.ncbi.nlm.nih.gov/42080790/). *Invest Ophthalmol Vis Sci*. [Review / Meta-Analysis]
Holz FG (2026). [PMID: 41124203](https://pubmed.ncbi.nlm.nih.gov/41124203/). *The New England journal of medicine*. [Clinical Trial Publication]
Temkar S (2026). [PMID: 42054088](https://pubmed.ncbi.nlm.nih.gov/42054088/). *Indian J Ophthalmol*. [Review / Meta-Analysis]
Jeong H (2026). [PMID: 41519378](https://pubmed.ncbi.nlm.nih.gov/41519378/). *Ophthalmol Retina*. [Epidemiology / Natural History]
Li S (2026). [PMID: 41826348](https://pubmed.ncbi.nlm.nih.gov/41826348/). *Nat Commun*. [Epidemiology / Natural History]
